Cynosure Group’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,095
Closed -$217K 181
2026
Q1
$217K Hold
1,095
0.03% 196
2025
Q4
$294K Hold
1,095
0.03% 392
2025
Q3
$270K Hold
1,095
0.03% 357
2025
Q2
$327K Sell
1,095
-38
-3% -$11.6K 0.04% 359
2025
Q1
$354K Sell
1,133
-72
-6% -$25.4K 0.05% 220
2024
Q4
$424K Sell
1,205
-299
-20% -$108K 0.06% 146
2024
Q3
$532K Buy
1,504
+234
+18% +$76.9K 0.08% 146
2024
Q2
$385K Sell
1,270
-55
-4% -$16.8K 0.06% 230
2024
Q1
$459K Sell
1,325
-11,392
-90% -$4.15M 0.08% 128
2023
Q4
$4.46M Buy
12,717
+6,669
+110% +$2.15M 0.8% 25
2023
Q3
$1.86M Sell
6,048
-50
-0.8% -$15.8K 0.57% 47
2023
Q2
$1.88M Buy
+6,098
New +$1.77M 0.57% 44

Other funds holding ACN

Cynosure Group's ACN Position: Q2 2026 in Review

Cynosure Group sold out of Accenture (ACN) in Q2 2026, closing a stake of 1,095 shares — an estimated $217K sold.

Cynosure Group first reported a position in ACN in Q2 2023 and held it in 12 quarters. The position peaked at $4.46M in Q4 2023. 1,897 funds tracked by Wall St. Rank hold ACN as of Q2 2026.

  • Cynosure Group reported no remaining Accenture position as of Q2 2026 after selling out during the quarter.
  • Cynosure Group sold 1,095 Accenture shares in Q2 2026, an estimated $217K.
  • Cynosure Group first reported a position in Accenture in Q2 2023 and held it in 12 quarters.
  • Cynosure Group's Accenture position peaked at $4.46M in Q4 2023.
  • 1,897 funds tracked by Wall St. Rank held Accenture as of Q2 2026.

Based on Cynosure Group's 13F filing for Q2 2026, filed 5 Aug 2026.